Hei-Young Ku

The Contributions of Cytochromes P450 3A4 and 3A5 to the Metabolism of the Phosphodiesterase Type 5 Inhibitors Sildenafil, Udenafil, and Vardenafil

Hei-Young Ku, Hee-Jeong Ahn, Kyung‐Ah Seo et al. · Drug Metabolism and Disposition · 2008 · 52 citations

The monoterpenoids citral and geraniol are moderate inhibitors of CYP2B6 hydroxylase activity

Kyung‐Ah Seo, Hyunmi Kim, Hei-Young Ku et al. · Chemico-Biological Interactions · 2008 · 37 citations

Cyp2b6 Hydroxylase Activity, Biochemistry, Medicine +8

Identification and Characterization of Potent CYP2B6 Inhibitors in Woohwangcheongsimwon Suspension, an Herbal Preparation Used in the Treatment and Prevention of Apoplexy in Korea and China

Hyunmi Kim, Kwon-Bok Kim, Hei-Young Ku et al. · Drug Metabolism and Disposition · 2008 · 30 citations

Liquid chromatography/tandem mass spectrometry method for the simultaneous determination of vardenafil and its major metabolite, N-desethylvardenafil, in human plasma: Application to a pharmacokinetic study

Hei-Young Ku, Ji‐Hong Shon, Kwang‐Hyeon Liu et al. · Journal of Chromatography B · 2008 · 28 citations

Major Metabolite, Gas Chromatography, Medicine +10

The disposition of three phosphodiesterase type 5 inhibitors, vardenafil, sildenafil, and udenafil, is differently influenced by the CYP3A5 genotype

Ji‐Hong Shon, Hei-Young Ku, Seol-Youn Bae et al. · Pharmacogenetics and Genomics · 2011 · 17 citations